RBM44
RNA-binding protein 44
Also known as: FLJ40411, RBM44_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZP01
- Gene
- RBM44
- Ensembl
- ENSG00000177483
- Chromosome
- 2
- Canonical length
- 1051 aa
- Protein class
- Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable protein homodimerization activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be located in cytoplasm and intercellular bridge. Predicted to be part of catalytic step 2 spliceosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1051 residues, UniProt reviewed canonical sequence.
>Q6ZP01|RBM44
1 MQATAVVETA SGKGYHSNGG NLQKDKPSNP KKENLLLSSN GCDEVKLTFP DDDWNSSTLE
61 QRANNKEISN IDKMDLLEPF FSVSQDTNTE STQFQSSELE DSTDYAFLNK TYSIPYSESK
121 LKKESLTPLS SELDPEVQKK EEVFFNILEH QDKTVGLERI YNISDANYRE SAEDTQKHDT
181 DEDSQQEYHS AEEQEYISNH LSFDQTKALD ISNPEVVELG NSGYEVKCAS NVEDNRVNSG
241 SGSIISFDSL DVYGQEESLH VSKFQNSVML REYHDLKHEK YKEQETNSMY HTVFDGSVLR
301 SNSPGNQESQ SKSGSLSPQK VLKMKIYTEN MKSQINEGKD FCGNKIVENK ILLHLENPST
361 LPQDKALETL LQPCKDCQTS WTSVFDDSII SACGYYESLQ NTADSALDFS AMLPKIAVRD
421 NQAIEDNTSL KVAHSSTTKK TCFHNIGEMC TKSLTDAASC TVTINQTVDV STDFRACFTT
481 SRATSARPSV VSTSSNTEIT MMNKKRPDEW QNEKQKSVAC STDWSYSEDC IDTQMAITKG
541 SGKSLSVDSL KPNGNFLNKD FLELRKACGI TDLKKHPERE FQLFKDTEKD LPSMCCQKIM
601 QRAIKAELHL LNVHYQMCRR HCCDIYKLVM ENREGLNMNL SSNSAKKELG SALLSLLGDL
661 KVRYVTLKEK IHKGIPLEEL PPLSLESKLL STFSTFASRL MKKETHVFSE ADAEQDNQRA
721 HDVDVSSNLK KTLSQMSLSS DNSHATQNIS PKKDDFKNGD INADFSQLKL GDKDCRHYQE
781 TSEDWSDAKE SLTGVDVSGT QGNQVEQDTW NLDLTGEMKN VEPSQRDKGY LIHVGGLCPS
841 VSEADLRSHF QKYQVSEISI YDSTNYRYAS LAFTKNSDAK IAVKEMNGIE INGKSVNVWP
901 VKILGEYTSP LSSKNGNRIS SNNLEKSTNK QIHSEFSISR LPRTRPRQLG SEQDSEVFPS
961 DQGVKKNCKQ IESAKLLPDT PVQFIPPNTL NLRSFTKIIK RLAELHPEVS RDHIINALQE
1021 VRIRHKGFLN GLSITTIVEM TSSLLKNSAS SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM44 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- testis: 15 nTPM
- blood vessel: 0.4 nTPM
- bone marrow: 0.4 nTPM
- lung: 0.4 nTPM
- adipose tissue: 0.3 nTPM
- breast: 0.3 nTPM
Single-cell type
- early primary spermatocytes: 123 nCPM
- differentiating spermatogonia: 68 nCPM
- endometrial luminal cells: 38 nCPM
- late primary spermatocytes: 29 nCPM
- early spermatids: 26 nCPM
- late spermatids: 25 nCPM
Immune cell
- basophil: 1.3 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- choroid plexus: 0.2 nTPM
- white matter: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- via spliceosome
- mRNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM44 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM44 as an antibody target. Whether an autoantibody or antibody against RBM44 could matter depends on whether native RBM44 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM44 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM44 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...